Fulcrum Therapeutics, Inc. (NASDAQ: FULC) today announced the pricing of its initial public offering of 4,500,000 shares of common stock ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE